Key numbers here is we are on track for $10m revenue for the year and a current MC of $10m.
The April upgraded license was discussed in a stock head article where the CEO spoke of $8m in orders already over the last 2 months. "we have been inundated with client and manufacturing orders "
Ann: BXN Signs Collaboration Agreement with Cy Biopharma AG, page-4
Add BXN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.59M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.2¢ | 1.2¢ | $5.313K | 442.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1652500 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 383683 | 1 |
View Market Depth
| Last trade - 13.55pm 08/11/2024 (20 minute delay) ? |
| BXN (ASX) Chart |